The effectiveness of TDF versus ETV on incidence of HCC in CHB patients: a meta analysis

Abstract Background It has been proved that nucleos(t) ide analogues (NAs) therapy could improve underlying liver disease and reduce the incidence of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC). However, the difference of effectiveness in reducing HCC occurrence between tenofovir...

Full description

Bibliographic Details
Main Authors: Zeyu Zhang, Yufan Zhou, Jiajin Yang, Kuan Hu, Yun Huang
Format: Article
Language:English
Published: BMC 2019-05-01
Series:BMC Cancer
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12885-019-5735-9